News and Events

How Melanoma Resists BRAF+MEK Inhibitor Combination Therapy

16 January 2015

Melanoma cells resist the combination therapy of BRAF+MEK inhibitors by developing highly unusual changes in certain key cancer genes, according authors of a recent study. These signature changes or configurations not only mark the presence of drug resistance melanoma cells but also indicate to researchers potential new ways to shut them off.

Children of Melanoma Survivors Need Sun Protection

13 January 2015

Children whose parents are melanoma survivors are not receiving the best possible protection from the sun and ultraviolet radiation, according to authors of a recent study. In their view, interventions among such high-risk populations may help reduce the burden of melanoma in the United States.

Predominant Role of Bad Luck of Random Mutations in Cancer

12 January 2015

Variation in cancer risk among tissues can be explained by the number of stem cell divisions, according to authors of a study published in Science in early January. In an associated media release, the authors highlight that the types of cancer that had a higher risk than predicted by the number of stem cell divisions include skin cancer (linked to sun exposure).

Scope for Health Promotion Among Small Outdoor Businesses

7 January 2015

Considerable scope exists for health promotion initiatives targeting sun protection specifically aimed at workers and owners of small outdoor businesses, according to researchers at the Behavioural Research and Evaluation Unit (BREU), Cancer Council SA.

Novel Gene Identified in Tanning Dependence

6 January 2015

Researchers led by the Yale School of Public Health have for the first time identified a gene that appears to be associated with tanning dependence. If replicated, the finding will help understand more about the biology of tanning dependence and possible interventions to reduce exposure.

Sunbed-Related Injuries in the USA

5 January 2015

A recent CDC (Center for Disease Control) study provides the first national estimates of indoor tanning–related injuries treated in US hospital emergency departments, according to its authors.

FDA Approves Opdivo (Nivolumab) for Advanced Melanoma

4 January 2015

The U.S. Food and Drug Administration has granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable or metastatic melanoma who no longer respond to other drugs.

2014 Melanoma Treatment Advances

3 January 2015

An end of year review published on-line in Medscape Oncology, with input from Antoni Ribas, MD, PhD, professor of medicine, David Geffen UCLA School of Medicine and Nancy Terry, editorial director for Medscape Oncology, highlights notable advances in melanoma from the past year.

Hair Shaft Micro RNA s a Marker for Melanoma

2 January 2015

In a recent study titled "Hair shaft miRNA-221 levels as a new tumour marker of malignant melanoma", published in The Journal of Dermatology, a team of researchers from Kumamoto University, Japan, assessed the hypothesis that hair shaft micro RNA (miR)-221 levels could be used as a marker for malignant melanoma (MM).

More Skin, More Sun, More Tan, More Melanoma

1 January 2015

Using a multidisciplinary approach, authors of a recent study have elucidated the evolution of behaviours maximizing UV exposure and consider public health and educational measures that may ultimately help reverse melanoma incidence trends.